Sánchez-Pérez, Jose Andrés
3270  results:
Search for persons X
?
4

Long- term enhancements in antidepressant efficacy and neur..:

Rasiel, Beltran-Casanueva ; Aracelis, Hernández-García ; Serrano-Castro, Pedro Jesús...
Beltran-casanueva R, Hernández-García A, Serrano-Castro PJ, et al. Long-term enhancements in antidepressant efficacy and neurogenesis: Effects of intranasal co-administration of neuropeptide Y 1 receptor (NPY1R) and galanin receptor 2 (GALR2) agonists in the ventral hippocampus. The FASEB Journal. 2024; 38:e23595. doi:10.1096/fj.202400087R.  , 2024
 
?
5

Decreased medial prefrontal cortex activity related to impa..:

Díaz-Sánchez, Estela ; López-Salas, Alexander ; Mirchandani-Duque, Marina...
Díaz-Sánchez E, López-Salas A, Mirchandani-Duque M, Alvarez-Contino JE, Sánchez-Pérez JA, Fuxe K, Borroto-Escuela DO, García-Casares N, Narváez M. Decreased medial prefrontal cortex activity related to impaired novel object preference task performance following GALR2 and Y1R agonists intranasal infusion. Biomed Pharmacother. 2023 May;161:114433. doi:10.1016/j.biopha.2023.114433. Epub 2023 Feb 26. PMID: 36848750..  , 2023
 
?
6

GALR2 and Y1R agonists intranasal infusion enhanced adultve..:

Álvarez-Contino, José Erik ; Díaz-Sánchez, Estela ; Mirchandani-Duque, Marina..
Alvarez‐Contino, J. E., Díaz‐Sánchez,E., Mirchandani‐Duque, M., Sánchez‐Pérez, J. A., Barbancho,M. A., López‐Salas, A., García‐Casares, N., Fuxe, K., Borroto‐Escuela, D. O., & Narváez, M. (2023). GALR2 and Y1Ragonists intranasal infusion enhanced adult ventralhippocampal neurogenesis and antidepressant‐like effectsinvolving BDNF actions.Journal of Cellular Physiology, 238,459–474.https://doi.org/10.1002/jcp.30944.  , 2023
 
?
 
?
8

Short-term outcomes by chronic betablocker treatment in pat..:

Jacob, Javier ; Haro, Antoni ; Tost, Josep...
European Heart Journal. Acute Cardiovascular Care.  11 (2022)  10 - p. 761-771 , 2022
 
?
 
?
 
1-15